SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amidst reports of potential federal marijuana rescheduling, sparking excitement around relaxed restrictions. Community discussions revolve around short squeeze potential and comparisons to other cannabis stocks. Investors are closely watching for further developments, with some expressing skepticism about the long-term impact.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending after earnings, with a mixed community sentiment as the stock experiences a sharp sell-off despite strong results and raised guidance, leading to speculation of manipulation and an AI bubble. Discussions revolve around the potential reasons for the decline, including profit-taking, margin concerns, and the overall market rotation out of tech. Despite the negative price action, many analysts have raised their price targets, fueling debate on whether this is a buying opportunity or a sign of further downside.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as investors discuss the potential for cannabis rescheduling, fueled by speculation around upcoming executive action and a Supreme Court review. Community members are weighing the implications of potential catalysts, with some anticipating a significant sector-wide breakout while others caution against hype-driven rallies. Discussion centers on the impact of rescheduling on US cannabis companies and strategies for trading sector momentum.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEO Group is trending amid discussions around immigration policy and potential impacts on the private prison sector, with some arguing about ethical concerns around profiting from incarceration. The community is also focused on ICE contracts and the company's financial outlook, specifically regarding potential gains, losses, and potential stock buybacks. GEO's stock performance and future prospects are debated, with some bullish and others expressing concerns about the company's management and the influence of political factors.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd

SUGP is trending as traders discuss its low float and potential for a significant breakout, drawing comparisons to other Hong Kong stocks like $SMX and $OCG. Community members highlight the possibility of a short squeeze and a golden cross setup, anticipating a run towards higher price levels. Traders are closely watching the stock's movement above the $6 and $8 levels as potential catalysts for further upward momentum.

Argo Blockchain Plc operates as a blockchain technology company focused on large-scale mining of Bitcoin and other cryptocurrencies. It mines using purpose-built computers to solve cryptographic algorithms in the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company was founded in 2017 and is headquartered in London, the United Kingdom.

Argo Blockchain Plc - ADR

Argo Blockchain Plc

Argo Blockchain is trending due to discussions around its reverse stock split and London Stock Exchange delisting, with the community debating potential impacts. Some traders anticipate a rebound and short squeeze given the low float post-split, while others express skepticism about the company's financial health and potential for further dilution. Overall, the conversation reflects a mix of speculative hope and concern amidst restructuring efforts.

RYTHM, Inc. engages in the development of hardware and software solutions for indoor agriculture. The company was founded on June 6, 2016 and is headquartered in Rolling Meadows, IL.

RYTHM Inc.

RYTHM Inc. is trending amid community discussions about potential catalysts from its pipeline and high trading volume. Some traders are debating the offering's risk and watching for short covering, while others are focused on technical analysis and potential for a significant price move. Active discussions and user disputes are contributing to the stock's visibility.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Aurora Cannabis is trending as the cannabis sector reacts to potential federal policy changes, particularly around rescheduling. Community discussions revolve around the perceived undervaluation of ACB, its international exposure, and whether it's lagging behind sector peers. Some traders speculate on short squeezes, while others caution against over-optimism, citing historical patterns of sector volatility and policy-related "pumps and dumps".

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending as investors debate the impact of delayed data center projects and increased capital expenditures on its debt load and AI initiatives; the community is closely watching for a potential bounce or further decline, analyzing technical indicators and management's response to negative news. Some traders view the dip as a buying opportunity, while others remain cautious about the company's financial strategy and competitive positioning in the cloud and AI market. Oracle's fluctuating stock price has sparked discussion about the broader health of the AI sector, with some suggesting it may be a sign of an overhyped market.

Wealthfront integrates investing and saving products to help young professionals build long-term wealth in any market condition. Through the power of software, the company delivers high-yield saving, diversified investing, and low-cost loans to help both sophisticated and new investors learn, lower costs, and grow wealth. Wealthfront is one of the highest rated financial apps in the Apple App Store and has been named Best Automated Investment App, Best Overall Robo-Advisor, and Best Robo-Advisor for Goal Planning by Investopedia (2022), Best Cash Management Account and Best Investing App by Bankrate (2023), Best Robo-Advisor for Portfolio Options by NerdWallet (2023), and Best Robo-Advisor for DIY Financial Planning by Forbes (2023). The company currently oversees more than $30 billion for over 500,000 clients in the US.

Wealthfront Corp.

Wealthfront ($WLTH) is trending following its IPO, with the community closely watching its debut and discussing its potential. The company's focus on millennial and Gen Z clients, along with its automated wealth management platform, are key talking points. Some are comparing it to other recent IPOs and anticipating a significant spike.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Upgraded to "Strong-Buy" at Lifesci Capital

Lifesci Capital raised shares of Eupraxia Pharmaceuticals to a "strong-buy" rating in a research note on Thursday...

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Average Rating of "Moderate Buy" by Brokerages

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the six research firms that are currently covering the firm...

Wall Street Zen Downgrades Eupraxia Pharmaceuticals (NASDAQ:EPRX) to Sell

Wall Street Zen cut Eupraxia Pharmaceuticals from a "hold" rating to a "sell" rating in a research note on Sunday...

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Upgraded at Wall Street Zen

Wall Street Zen raised shares of Eupraxia Pharmaceuticals to a "hold" rating in a report on Saturday...

FY2025 Earnings Forecast for EPRX Issued By HC Wainwright

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX - Free Report) - Research analysts at HC Wainwright boosted their FY2025 earnings estimates for Eupraxia Pharmaceuticals in a note issued to investors on...

Wall Street Analysts Think Eupraxia Pharmaceuticals Inc. (EPRX) Could Surge 75.08%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 75.1% in Eupraxia Pharmaceuticals Inc. (EPRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Is Elanco Animal Health (ELAN) Stock Outpacing Its Medical Peers This Year?

Here is how Elanco Animal Health Incorporated (ELAN) and Eupraxia Pharmaceuticals Inc. (EPRX) have performed compared to their sector so far this year.

Eupraxia Pharmaceuticals Inc. (EPRX) is a Great Momentum Stock: Should You Buy?

Does Eupraxia Pharmaceuticals Inc. (EPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Eupraxia Pharmaceuticals Inc. (EPRX) Upgraded to Buy: Here's Why

Eupraxia Pharmaceuticals Inc. (EPRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Wall Street Analysts Believe Eupraxia Pharmaceuticals Inc. (EPRX) Could Rally 85.12%: Here's is How to Trade

The consensus price target hints at an 85.1% upside potential for Eupraxia Pharmaceuticals Inc. (EPRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Eupraxia Pharmaceuticals, Inc. operates as a drug delivery technology company in Canada. It delivers drugs into body compartments, such as the joint without any of the common issues with body compartment injections, such as systemic exposure. The firm focuses on arthritis, diabetic macular edema, and chronic pain programs. The company was founded by James A. Helliwell, John Salvatore Montalbano and Amanda Malone on May 12, 2011 and is headquartered in Victoria, Canada.

Current Price	$6.26
Prev Close	$6.40
Open	$6.58
Dividend Yield	0.00%
50-Day Moving Average	$5.97
Beta	0.49
Avg. Volume	173,654.63
PE Ratio	-7.37

52-Week High	$7.19
52-Week Low	$2.68
Market Capitalization	$324.15M
EPS (Annual)	-$0.7516
Price to Book	5.55
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

EPRX
Eupraxia Pharmaceuticals Inc

Feed

News

Sentiment

Fundamentals

Info

Latest EPRX News

EPRXEupraxia Pharmaceuticals Inc